Reported Earlier, Latigo Biotherapeutics Files To Sell Up To 16M IPO Shares Priced At $16-$18 Per Share
This is an initial public offering of shares of common stock of Latigo Biotherapeutics, Inc. We are offering 16,000,000 shares of our common stock to be sold in this offering.Prior to this offering, there has been no
Latigo Biotherapeutics is selling 16 million shares to the public for the first time, with each share priced between $16 and $18. When a company goes public like this, it's a chance to watch if lots of people want to buy in, which shows if they believe in the company's work.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.